title: Pacemaker infections due to rapidly growing mycobacteria: further experience.
authors.forename: Wai On
authors.initials: WO
authors.lastname: Tam
authors.forename: Wing Wai
authors.initials: WW
authors.lastname: Yew
authors.forename: Wing Cheong
authors.initials: WC
authors.lastname: Yam
authors.forename: Kwok Yung
authors.initials: KY
authors.lastname: Yuen
authors.forename: Poon Chuen
authors.initials: PC
authors.lastname: Wong
authors.forename: Tak Fu
authors.initials: TF
authors.lastname: Tse
mesh_terms: D000081:Acetamides / Q000627:therapeutic use; D000368:Aged; D000890:Anti-Infective Agents / Q000627:therapeutic use*; D017291:Clarithromycin / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D000069349:Linezolid; D009164:Mycobacterium Infections / Q000188:drug therapy / Q000382:microbiology*; D015242:Ofloxacin / Q000627:therapeutic use; D023303:Oxazolidinones / Q000627:therapeutic use; D010138:Pacemaker, Artificial / Q000009:adverse effects*; D016459:Prosthesis-Related Infections / Q000188:drug therapy / Q000382:microbiology*; D013530:Surgical Wound Infection / Q000188:drug therapy / Q000382:microbiology*
chemical_list: D000081:Acetamides; D000890:Anti-Infective Agents; D023303:Oxazolidinones; D015242:Ofloxacin; D017291:Clarithromycin; D000069349:Linezolid